Optimization of prostate cancer cell detection using multiplex tyramide signal amplification

Area of Science:

• Oncology
• Biomedical Engineering
• Pathology

Background:

• Prostate cancer (PCa) bone metastasis is a leading cause of mortality, often stemming from undetected dissemination.
• Current methods for assessing PCa spread and aggressiveness are limited, hindering early diagnosis and effective treatment.
• Traditional immunohistochemistry (IHC) can only analyze one or two proteins per tissue section, limiting comprehensive analysis.

Purpose of the Study:

• To develop a novel, multiplex immunofluorescence staining protocol for analyzing multiple proteins in PCa.
• To enhance the detection and characterization of PCa dissemination and aggressiveness.
• To provide a flexible and informative assay for improving PCa detection, diagnosis, and treatment strategies.

Main Methods:

• Developed a tyramide-based immunofluorescence staining protocol to detect seven proteins simultaneously in PCa tissues and liquid biopsies.
• Optimized the protocol to amplify signal and reduce background noise, improving the signal-to-noise ratio.
• Demonstrated the protocol's flexibility by showing that any protein-specific antibody can be interchanged.

Main Results:

• Successfully detected a panel of seven proteins in primary PCa tumor biopsies, metastatic autopsy tissues, and liquid biopsies.
• The novel protocol significantly enhances signal detection and reduces background noise compared to traditional methods.
• The assay proved to be highly informative and adaptable for various PCa sample types.

Conclusions:

• The developed immunofluorescence protocol offers a powerful tool for detailed analysis of PCa.
• This method can provide crucial insights into PCa metastasis and tumor aggressiveness.
• The protocol has the potential to significantly improve the detection, diagnosis, and treatment of prostate cancer.